The resulting gene expression changes led to elevated serum levels of tri-antennary, tri-sialylated, and mono-fucosylated glycans of AAT-A3F in patients with non-alcoholic steatohepatitis, compared to patients who had non-alcoholic fatty liver. Here, SERPINA1 is linked to metabolic dysfunction-associated steatohepatitis.